The Food and Drug Administration approved Novo Nordisk’s Ozempic as the first GLP-1 treatment option for people with type 2 ...
Many of modern medicine's most remarkable achievements have been accomplished through the trust of volunteers, who test new drugs, procedures and medical devices to determine if they are safe and ...
A sorbet-filled mochi recalled due to an undeclared allergen has been given the U.S. Food and Drug Administration (FDA)'s ...
Robert F. Kennedy Jr., was pressed to clarify his views on vaccines, abortion and public health priorities in the first of ...
The active ingredient is used in the morning-after pill commonly marketed as “ella” or “ellaOne,” which is advertised as a ...
Robert F. Kennedy Jr., President Donald Trump's pick to lead the top U.S. health agency, told U.S. senators during his ...
In a Senate hearing, Robert F. Kennedy, Jr. said that efforts to address the high rates of chronic disease need to start with ...
Senators grilled Robert F. Kennedy Jr. on if and how he would reform Medicaid and Medicare during his first confirmation ...
The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...
Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...
Ozempic, or semaglutide, can now be used to reduce the risk of worsening kidney disease or kidney failure in adults with type ...
A front-of-package food label would be a great educational tool. The Trump administration should keep it.